Osteocytes, RANKL and bone loss

被引：5
|
作者：
Carol Wilson
机构：
来源：
Nature Reviews Endocrinology | 2011年 / 7卷 / 12期
关键词：
D O I：
10.1038/nrendo.2011.176
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：693 / 693
相关论文
共 50 条
  • [1] RANKL produced by osteocytes is required for cortical, but not cancellous, bone loss with age
    Xiong, Jinhu
    Cawley, Keisha
    Macleod, Ryan
    Almeida, Maria
    Obrien, Charles
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 12 - 12
  • [2] Disuse sufficient to cause bone loss increases osteocytes' expression of sclerostin but has no effect on osteocyte RANKL
    Delisser, Peter
    Meakin, Lee
    Galea, Gabriel
    Lanyon, Lance
    Suva, Larry
    Price, Joanna
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [3] The Role of Osteocytes in Inflammatory Bone Loss
    Metzger, Corinne E.
    Narayanan, S. Anand
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [4] Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice
    Piemontese, Marilina
    Xiong, Jinhu
    Fujiwara, Yuko
    Thostenson, Jeff D.
    O'Brien, Charles A.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2016, 311 (03): : E587 - E593
  • [5] Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin-/- mice through increasing sclerostin and RANKL/OPG
    Ma, Jiawei
    Wang, Aifei
    Zhang, Hui
    Liu, Baoshan
    Geng, Yu
    Xu, Youjia
    Zuo, Guilai
    Jia, Peng
    BONE, 2022, 164
  • [6] The Role of Osteocytes in Age-Related Bone Loss
    Robert L. Jilka
    Charles A. O’Brien
    Current Osteoporosis Reports, 2016, 14 : 16 - 25
  • [7] The Role of Osteocytes in Age-Related Bone Loss
    Jilka, Robert L.
    O'Brien, Charles A.
    CURRENT OSTEOPOROSIS REPORTS, 2016, 14 (01) : 16 - 25
  • [8] IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production
    Li, Jau-Yi
    Yu, Mingcan
    Tyagi, Abdul Malik
    Vaccaro, Chiara
    Hsu, Emory
    Adams, Jonathan
    Bellido, Teresita
    Weitzmann, M. Neale
    Pacifici, Roberto
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (02) : 349 - 360
  • [9] Denosumab: RANKL inhibition in the management of bone loss
    Hamdy, N. A. T.
    DRUGS OF TODAY, 2008, 44 (01) : 7 - 21
  • [10] Role of RANKL and RANK in bone loss and arthritis
    Jones, DH
    Kong, YY
    Penninger, JM
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 : 32 - 39
12345